PL3727037T3 - Kompozycje lizofosfatydylocholiny - Google Patents

Kompozycje lizofosfatydylocholiny

Info

Publication number
PL3727037T3
PL3727037T3 PL18855122.0T PL18855122T PL3727037T3 PL 3727037 T3 PL3727037 T3 PL 3727037T3 PL 18855122 T PL18855122 T PL 18855122T PL 3727037 T3 PL3727037 T3 PL 3727037T3
Authority
PL
Poland
Prior art keywords
lysophosphatidylcholine
compositions
lysophosphatidylcholine compositions
Prior art date
Application number
PL18855122.0T
Other languages
English (en)
Inventor
Nils Hoem
Finn Myhren
Petter-Arnt HALS
Armend Håti
Original Assignee
Aker Biomarine Human Ingredients As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aker Biomarine Human Ingredients As filed Critical Aker Biomarine Human Ingredients As
Publication of PL3727037T3 publication Critical patent/PL3727037T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings or cooking oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00Phosphatide compositions for foodstuffs, e.g. lecithin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00Production of fats or fatty oils from raw materials
    • C11B1/02Pretreatment
    • C11B1/025Pretreatment by enzymes or microorganisms, living or dead
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/18Lipids
    • A23V2250/184Emulsifier
    • A23V2250/1846Phosphatidyl Choline
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/18Lipids
    • A23V2250/186Fatty acids
    • A23V2250/1882Polyunsaturated fatty acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/612Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/001Amines; Imines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
PL18855122.0T 2017-12-21 2018-12-21 Kompozycje lizofosfatydylocholiny PL3727037T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762608891P 2017-12-21 2017-12-21
US201862725683P 2018-08-31 2018-08-31
PCT/IB2018/001588 WO2019123015A1 (en) 2017-12-21 2018-12-21 Lysophosphatidylcholine compositions

Publications (1)

Publication Number Publication Date
PL3727037T3 true PL3727037T3 (pl) 2026-01-19

Family

ID=65685831

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18855122.0T PL3727037T3 (pl) 2017-12-21 2018-12-21 Kompozycje lizofosfatydylocholiny

Country Status (15)

Country Link
US (3) US11065267B2 (pl)
EP (1) EP3727037B1 (pl)
JP (1) JP7625416B2 (pl)
KR (2) KR20240135688A (pl)
CN (1) CN111902053A (pl)
AU (1) AU2018389595B2 (pl)
BR (1) BR112020012705A2 (pl)
CA (1) CA3086416A1 (pl)
ES (1) ES3052913T3 (pl)
IL (1) IL275534B2 (pl)
MX (1) MX2020006529A (pl)
PL (1) PL3727037T3 (pl)
PT (1) PT3727037T (pl)
SG (1) SG11202005905TA (pl)
WO (1) WO2019123015A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240135688A (ko) 2017-12-21 2024-09-11 에이커 바이오마린 앤탁틱 에이에스 리소포스파티딜콜린 조성물
WO2020081513A1 (en) * 2018-10-16 2020-04-23 Systamedic Inc. Novel compositions for the treatment of inflammatory diseases
WO2020254675A1 (en) 2019-06-20 2020-12-24 Aker Biomarine Antarctic As Parenteral lysophosphatidylcholine formulations such as lpc-dha, lpc-epa and their use in therapy
NL2023407B1 (en) * 2019-06-28 2021-02-01 Aker Biomarine Antarctic As Parenteral lysophosphatidylcholine formulations
CN110564786B (zh) * 2019-08-02 2022-06-03 大渔华创(广州)海洋生物科技有限公司 一种epa/dha型溶血磷脂组合物及其制备方法
WO2021132516A1 (ja) * 2019-12-26 2021-07-01 マルハニチロ株式会社 多価不飽和脂肪酸が結合したリン脂質を含む魚卵脂質組成物
EP4125855A2 (en) 2020-03-31 2023-02-08 Aker Biomarine Antarctic As Krill oil composition enriched in lpc-dha and lpc-epa
WO2022006711A1 (en) * 2020-07-06 2022-01-13 Kemin Industries, Inc. Method for the preparation of lysophosphatidylinositol
WO2022101678A2 (en) 2020-11-15 2022-05-19 Aker Biomarine Antarctic As Lysophospholipid formulations
US12173254B2 (en) * 2020-12-08 2024-12-24 Orochem Technologies Inc. Process for purifying LPC-DHA and/or LPC-EPA using a chromatographic stationary phase and compositions thereof
KR20250089549A (ko) 2022-11-01 2025-06-18 에이커 바이오마린 휴먼 인그리디언트 에이에스 치료 화합물의 전달을 위한 인지질 조성물

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0657715B2 (ja) * 1987-04-09 1994-08-03 キユーピー株式会社 Lpc以外のリゾ型リン脂質をほとんど含まないリゾリン脂質の製造方法
FR2698269B1 (fr) 1992-11-24 1995-01-06 Inst Nat Sante Rech Med Nouveaux médicaments à base d'acides gras insaturés, utilisables notamment comme antiagrégants plaquettaires et/ou comme transporteurs privilégiés vers le cerveau.
EP1814402A2 (en) 2004-11-17 2007-08-08 Natural ASA Enzymatically synthesized marine phospholipids
JP2006197842A (ja) * 2005-01-20 2006-08-03 Shizuoka Prefecture ホスホリパーゼa1活性を有する組成物、それを用いて得られる2−アシル型リゾリン脂質、及びそれらの製造方法
US20080044487A1 (en) 2006-05-05 2008-02-21 Natural Asa Anti-inflammatory properties of marine lipid compositions
US20080021000A1 (en) 2006-07-19 2008-01-24 Su Chen Mixtures of and methods of use for polyunsaturated fatty acid-containing phospholipids and alkyl ether phospholipids species
EP2085089A1 (en) * 2008-02-01 2009-08-05 KTB-Tumorforschungs GmbH Phospholipids Containing omega-3-Fatty Acids for the Treatment of Overweight, Obesity and Addictive Behavior
US20090281065A1 (en) 2008-05-09 2009-11-12 Kemin Industries, Inc. Use of Lysophospholipids to Treat Inflammation
US9814256B2 (en) * 2009-09-14 2017-11-14 Rimfrost Technologies As Method for processing crustaceans to produce low fluoride/low trimethyl amine products thereof
US8906886B2 (en) 2009-07-03 2014-12-09 Su Chen Composition and method for promoting survival of aged basal forebrain cholinergic neuron leading to provention and treatment of age-related neurodegenerative disorder
AU2009354456B2 (en) * 2009-10-30 2014-05-08 Tharos Ltd Solvent-free process for obtaining phospholipids and neutral enriched krill oils
CN103140587B (zh) 2010-09-30 2016-06-22 国立大学法人东京海洋大学 含2-酰基-溶血磷脂酰丝氨酸的组合物及其制造方法
JP6058933B2 (ja) 2012-07-26 2017-01-11 キヤノン株式会社 動画処理装置およびその制御方法、プログラム並びに記憶媒体
MX372724B (es) 2012-12-24 2020-06-19 Qualitas Health Inc Formulaciones de acido eicosapentaenoico (epa).
JP6692748B2 (ja) 2013-09-26 2020-05-13 ナショナル ユニヴァーシティー オブ シンガポール リゾホスファチジルコリンの足場を利用する組成物及び方法
WO2015069097A1 (en) 2013-11-08 2015-05-14 N.V. Nutricia Efficacy of dietary dha-phospholipid for brain dha and dpa accretion in neonates
ES2937960T5 (en) 2015-02-11 2026-02-16 Aker Biomarine Human Ingredients As Lipid extraction processes
US9556116B2 (en) 2015-02-11 2017-01-31 Orochem Technologies, Inc. Krill oil refinery for purification of krill oil extract
EP3256553A2 (en) 2015-02-11 2017-12-20 Aker Biomarine Antarctic AS Lipid compositions
JP6763521B2 (ja) * 2016-05-23 2020-09-30 国立大学法人北海道大学 2−dha−リゾホスファチジルコリン含有脂質組成物及びその製造方法
CA3043920A1 (en) * 2016-12-09 2018-06-14 Balchem Corporation Essential nutrients and related methods
US10555957B2 (en) * 2017-05-10 2020-02-11 The Board Of Trustees Of The University Of Illinois Methods and compositions for enriching DHA levels in the brain
KR20240135688A (ko) 2017-12-21 2024-09-11 에이커 바이오마린 앤탁틱 에이에스 리소포스파티딜콜린 조성물

Also Published As

Publication number Publication date
PT3727037T (pt) 2025-11-13
JP2021508343A (ja) 2021-03-04
ES3052913T3 (en) 2026-01-15
KR20200128656A (ko) 2020-11-16
US20250090561A1 (en) 2025-03-20
KR102704572B1 (ko) 2024-09-06
WO2019123015A8 (en) 2020-08-06
JP7625416B2 (ja) 2025-02-03
KR20240135688A (ko) 2024-09-11
US20210338697A1 (en) 2021-11-04
US12076333B2 (en) 2024-09-03
BR112020012705A2 (pt) 2020-11-24
EP3727037B1 (en) 2025-10-08
AU2018389595B2 (en) 2024-10-10
IL275534A (en) 2020-08-31
SG11202005905TA (en) 2020-07-29
CA3086416A1 (en) 2019-06-27
US20190201424A1 (en) 2019-07-04
US11065267B2 (en) 2021-07-20
EP3727037A1 (en) 2020-10-28
CN111902053A (zh) 2020-11-06
WO2019123015A1 (en) 2019-06-27
AU2018389595A1 (en) 2020-07-09
MX2020006529A (es) 2021-01-08
IL275534B2 (en) 2024-09-01
IL275534B1 (en) 2024-05-01

Similar Documents

Publication Publication Date Title
DK3665237T3 (en) Compositions
IL261792B (en) Preparations
IL275534A (en) Lysophosphatidylcholine compounds
IL260933A (en) Preparations containing tocorsol or its analogues
GB201610156D0 (en) Cliptac compositions
SG11201705415YA (en) Multi-supplement compositions
IL257131A (en) Preparations
GB201515387D0 (en) Compositions
GB201501598D0 (en) Compositions
IL256559B1 (en) Flinbolin preparations
GB201515391D0 (en) Compositions
GB201719480D0 (en) Compositions
GB201707909D0 (en) Compositions
GB201707454D0 (en) Compositions
GB201622161D0 (en) Compositions
GB201614799D0 (en) Compositions
PL3609464T3 (pl) Kompozycje na bazie ksantohumolu
GB2538335B (en) Compositions
GB201602658D0 (en) Compositions
IL269120A (en) Compositions comprising avelumab
GB201717712D0 (en) Compositions
GB201703136D0 (en) Compositions
PL3393503T3 (pl) Kompozycje
HK40039594A (en) Lysophosphatidylcholine compositions
HK40039594B (en) Lysophosphatidylcholine compositions